Singh TG - Search Results

1

Expanding the Arsenal Against Huntington's Disease-Herbal Drugs and Their Nanoformulations.

Vishwas S, Gulati M, Kapoor B, Gupta S, Singh SK, Awasthi A, Khan A, Goyal A, Bansal A, Baishnab S, Singh TG, Arora S, Porwal O, Kumar A, Kumar V. Vishwas S, et al. Among authors: singh sk, singh tg. Curr Neuropharmacol. 2021;19(7):957-989. doi: 10.2174/1570159X18666201109090824. Curr Neuropharmacol. 2021. PMID: 33167841 Free PMC article. Review.

2

Involvement of cyclic adenosine diphosphoribose receptor activation in ischemic preconditioning induced protection in mouse brain.

Rehni AK, Singh TG, Bhateja P, Singh N, Arora S. Rehni AK, et al. Among authors: singh n, singh tg. Brain Res. 2010 Jan 14;1309:75-82. doi: 10.1016/j.brainres.2009.10.071. Epub 2009 Nov 6. Brain Res. 2010. PMID: 19896931

3

Tramadol-induced seizurogenic effect: a possible role of opioid-dependent histamine H1 receptor activation-linked mechanism.

Rehni AK, Singh TG, Singh N, Arora S. Rehni AK, et al. Among authors: singh n, singh tg. Naunyn Schmiedebergs Arch Pharmacol. 2010 Jan;381(1):11-9. doi: 10.1007/s00210-009-0476-y. Epub 2009 Dec 10. Naunyn Schmiedebergs Arch Pharmacol. 2010. PMID: 20012267

4

Possible involvement of ubiquitin proteasome system and other proteases in acute and delayed aspects of ischemic preconditioning of brain in mice.

Rehni AK, Singh TG, Behl N, Arora S. Rehni AK, et al. Among authors: singh tg. Biol Pharm Bull. 2010;33(12):1953-7. doi: 10.1248/bpb.33.1953. Biol Pharm Bull. 2010. PMID: 21139232 Free article.

5

Involvement of src-kinase activation in ischemic preconditioning induced protection of mouse brain.

Rehni AK, Singh TG, Kakkar T, Arora S. Rehni AK, et al. Among authors: singh tg. Life Sci. 2011 May 9;88(19-20):825-9. doi: 10.1016/j.lfs.2011.02.024. Epub 2011 Mar 15. Life Sci. 2011. PMID: 21396377

6

SU-6656, a selective Src kinase inhibitor, attenuates mecamylamine-precipitated nicotine withdrawal syndrome in mice.

Rehni AK, Singh TG, Arora S. Rehni AK, et al. Among authors: singh tg. Nicotine Tob Res. 2012 Apr;14(4):407-14. doi: 10.1093/ntr/ntr228. Epub 2011 Nov 18. Nicotine Tob Res. 2012. PMID: 22102627

7

Ro 32-0432 attenuates mecamylamine-precipitated nicotine withdrawal syndrome in mice.

Singh TG, Rehni AK, Arora S. Singh TG, et al. Naunyn Schmiedebergs Arch Pharmacol. 2013 Mar;386(3):197-204. doi: 10.1007/s00210-012-0825-0. Epub 2012 Dec 29. Naunyn Schmiedebergs Arch Pharmacol. 2013. PMID: 23274455

8

Pharmacological modulation of farnesyltransferase subtype I attenuates mecamylamine-precipitated nicotine withdrawal syndrome in mice.

Singh TG, Rehni AK, Arora SK. Singh TG, et al. Behav Pharmacol. 2013 Dec;24(8):668-77. doi: 10.1097/FBP.0000000000000009. Behav Pharmacol. 2013. PMID: 24196026

9

Alzheimer's Disorder: Epigenetic Connection and Associated Risk Factors.

Sharma VK, Mehta V, Singh TG. Sharma VK, et al. Among authors: singh tg. Curr Neuropharmacol. 2020;18(8):740-753. doi: 10.2174/1570159X18666200128125641. Curr Neuropharmacol. 2020. PMID: 31989902 Free PMC article. Review.

10

Role of Nuclear Factor Kappa B (NF-κB) Signalling in Neurodegenerative Diseases: An Mechanistic Approach.

Singh S, Singh TG. Singh S, et al. Among authors: singh tg. Curr Neuropharmacol. 2020;18(10):918-935. doi: 10.2174/1570159X18666200207120949. Curr Neuropharmacol. 2020. PMID: 32031074 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

208 results

Search Page

Filters